Propella Therapeutics, a development-stage venture focused on accelerated approvals of therapeutics with what it calls “mitigated risk,” now calls Pittsboro home.
New therapeutic company emerges in Pittsboro after a corporate reorganization
Propella Therapeutics, a development-stage venture focused on accelerated approvals of therapeutics with what it calls “mitigated risk,” now calls Pittsboro home.